• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乙型肝炎表面抗原抗体浓度的标准化。

Standardization of the antibody to hepatitis B surface antigen concentration.

作者信息

Richardson S C, Papaevangelou G, Roumeliotou-Karayannis A

出版信息

J Biol Stand. 1985 Apr;13(2):101-6. doi: 10.1016/s0092-1157(85)80014-7.

DOI:10.1016/s0092-1157(85)80014-7
PMID:3158661
Abstract

We examine sources of potential bias in the estimation of antibody to hepatitis B surface antigen concentrations by a calibration curve for conversion of RIA units to international units. We show by calculation and example that very large biases may exist, whereas accurate estimation is needed in screening programmes and in clinical trials for the evaluation of the immunogenicity of various types and schedules of hepatitis B vaccine. It is recommended that the danger of large biases be avoided by using the laboratory's own calibration curve, calibrated against dilutions of the WHO standard, using a standard as positive control in the radioimmunoassay. Furthermore, serum samples should be diluted to a concentration close to that of the positive control.

摘要

我们通过将放射免疫分析(RIA)单位转换为国际单位的校准曲线,研究了乙型肝炎表面抗原抗体浓度估计中潜在偏差的来源。我们通过计算和实例表明,可能存在非常大的偏差,而在筛查计划和评估各种类型及接种方案的乙型肝炎疫苗免疫原性的临床试验中,需要进行准确估计。建议通过使用实验室自身根据世界卫生组织标准稀释液校准的校准曲线,并在放射免疫分析中使用标准品作为阳性对照,来避免出现大偏差的风险。此外,血清样本应稀释至接近阳性对照的浓度。

相似文献

1
Standardization of the antibody to hepatitis B surface antigen concentration.乙型肝炎表面抗原抗体浓度的标准化。
J Biol Stand. 1985 Apr;13(2):101-6. doi: 10.1016/s0092-1157(85)80014-7.
2
Antibody to hepatitis B surface antigen and screening before hepatitis B vaccination.乙型肝炎表面抗原抗体及乙肝疫苗接种前筛查。
Ann Intern Med. 1985 Nov;103(5):791-3. doi: 10.7326/0003-4819-103-5-791.
3
Efficacy of hepatitis B vaccine.乙肝疫苗的功效
J Soc Occup Med. 1988 Spring-Summer;38(1-2):46-7. doi: 10.1093/occmed/38.1-2.46.
4
Response to hepatitis B vaccine of persons positive for antibody to hepatitis B core antigen.乙肝核心抗原抗体阳性者对乙肝疫苗的反应。
Gastroenterology. 1992 Aug;103(2):590-4. doi: 10.1016/0016-5085(92)90851-o.
5
[Detection of antibodies and assessment of an international unit of anti-HBs specific immunoglobulin, HEPAGA].
Cas Lek Cesk. 1989 Jun 16;128(25):777-80.
6
[Specific safety and immunogenicity of a subunit vaccine against hepatitis B].[一种乙型肝炎亚单位疫苗的特异性安全性和免疫原性]
Vopr Virusol. 1985 May-Jun;30(3):324-7.
7
Comparison of two techniques for detecting antibody to HBsAg during a hepatitis B vaccine study.一项乙肝疫苗研究中两种检测乙肝表面抗原抗体技术的比较。
J Virol Methods. 1985 Apr;10(4):333-9. doi: 10.1016/0166-0934(85)90050-3.
8
Qualitative analysis of the humoral immune response to the "a" determinant of HBs antigen after inoculation with plasma-derived or recombinant vaccine.接种血浆源性或重组疫苗后对乙肝表面抗原“a”决定簇体液免疫反应的定性分析。
J Med Virol. 1987 Feb;21(2):155-60. doi: 10.1002/jmv.1890210207.
9
[Limited value of anti-HBs determination following vaccination against hepatitis B].[乙肝疫苗接种后抗-HBs检测的有限价值]
Ned Tijdschr Geneeskd. 1987 Aug 15;131(33):1443-4.
10
A collaborative study to establish the International Reference Reagent for hepatitis B vaccine containing plasma-derived hepatitis B surface antigen.
J Biol Stand. 1989 Apr;17(2):151-60. doi: 10.1016/0092-1157(89)90005-x.